Drug profile

The FDA adverse-event record for S-Adenosylmethionine

376 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference S-Adenosylmethionine. See the species affected, top reactions, and outcomes below.

376
adverse-event reports
12.2%
death-coded share
Dog
most-reported species
77
Vomiting - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
376
Total Reports
46
Deaths Reported
12.2%
Death Rate

Active Ingredients

S-Adenosylmethionine

Administration Routes

OralUnknown

Species Affected

Dog 363
Cat 13

Most Affected Breeds

Retriever - Labrador 50
Chihuahua 19
Crossbred Canine/dog 17
Shih Tzu 16
Schnauzer - Miniature 16
Terrier - Yorkshire 15
Maltese 15
Shepherd Dog - German 11
Terrier - Boston 11
Beagle 10

Most Reported Reactions

Vomiting 77
Elevated alanine aminotransferase (ALT) 71
Emesis 59
Lethargy (see also Central nervous system depression in 'Neurological') 55
Elevated serum alkaline phosphatase (SAP) 53
Other abnormal test result NOS 49
Elevated liver enzymes 44
Diarrhoea 42
Anorexia 32
Death by euthanasia 28
Weight loss 27
Elevated total bilirubin 26

Outcome Breakdown

Recovered/Normal
132 (35.1%)
Outcome Unknown
93 (24.7%)
Ongoing
88 (23.4%)
Euthanized
28 (7.4%)
Died
18 (4.8%)
Recovered with Sequela
17 (4.5%)

S-Adenosylmethionine Adverse Event Insights

376 reports name S-Adenosylmethionine; 46 recorded a death outcome (12.2% of reported events, not a population-level mortality rate). Active ingredient: S-Adenosylmethionine. Administration routes: Oral, Unknown.

By species: Dog (363 reports), Cat (13 reports). By breed: Retriever - Labrador (50), Chihuahua (19), Crossbred Canine/dog (17).

Leading clinical signs: Vomiting (77), Elevated alanine aminotransferase (ALT) (71), Emesis (59), Lethargy (see also Central nervous system depression in 'Neurological') (55). Outcome, 376 coded reports: Recovered/Normal leads at 35.1%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.